Bluejay Diagnostics Announces Sepsis Dataset Details for Symphony IL-6 Test
Bluejay Diagnostics released preliminary clinical data from the SYMON-II study supporting the Symphony IL-6 test's potential for mortality risk assessment in sepsis, marking a key milestone toward regulatory submission.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed